Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Gingival fibromatosis - facial dysmorphism is a very rare syndrome characterized by the association of gingival fibromatosis and craniofacial dysmorphism.
Features include very common findings: Gingival fibromatosis, Gingival overgrowth, High palate, and Macrocephaly and others; and common findings: Everted lower lip vermilion and Exaggerated cupid's bow.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 3 | High palate, Everted lower lip vermilion, Macrocephaly |
Biomarker and diagnostic research for gingival fibromatosis-facial dysmorphism syndrome has been reported in the published literature.
Phenotype severity distribution: 12 very common features, 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for gingival fibromatosis-facial dysmorphism syndrome.
51 publications have been identified in PubMed for gingival fibromatosis-facial dysmorphism syndrome. Research spans Case Report / Case Series (49%), Review / Meta-Analysis (14%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 25 | 49% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 9:47 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Brain and nerves
1 |
Depressed nasal bridge |
Research summaries
7 |
14% |
Laboratory research | 6 | 12% |
Disease patterns and progression | 6 | 12% |
Clinical study results | 3 | 6% |
Other research | 2 | 4% |
Testing and diagnosis research | 1 | 2% |
New treatment approaches | 1 | 2% |
Bhandary R (2026). [PMID: 40828338](https://pubmed.ncbi.nlm.nih.gov/40828338/). *Eur Arch Paediatr Dent*. [Case Report / Case Series]
Matsumura R (2026). [PMID: 41730960](https://pubmed.ncbi.nlm.nih.gov/41730960/). *Sci Rep*. [Basic Science / Preclinical]
Jogigowda SC (2026). [PMID: 41825905](https://pubmed.ncbi.nlm.nih.gov/41825905/). *BMJ Case Rep*. [Case Report / Case Series]
Adelman AE (2026). [PMID: 41451697](https://pubmed.ncbi.nlm.nih.gov/41451697/). *Otolaryngol Head Neck Surg*. [Other]
Dutra Oliveira AMS (2026). [PMID: 39812307](https://pubmed.ncbi.nlm.nih.gov/39812307/). *Clin Adv Periodontics*. [Case Report / Case Series]
Almpani K (2026). [PMID: 40611650](https://pubmed.ncbi.nlm.nih.gov/40611650/). *Cleft Palate Craniofac J*. [Other]
Sriwattanapong K (2026). [PMID: 40693438](https://pubmed.ncbi.nlm.nih.gov/40693438/). *Cell Prolif*. [Basic Science / Preclinical]
Lodato V (2026). [PMID: 40605398](https://pubmed.ncbi.nlm.nih.gov/40605398/). *Clin Genet*. [Case Report / Case Series]
Gao Q (2026). [PMID: 41290531](https://pubmed.ncbi.nlm.nih.gov/41290531/). *J Oral Pathol Med*. [Gene Therapy / Novel Therapeutics]
Yamaguti PM (2025). [PMID: 40457511](https://pubmed.ncbi.nlm.nih.gov/40457511/). *Clin Genet*. [Case Report / Case Series]